Table 1 presents a comparison of the clinical, laboratory, and demographic data of the NAFLD and control groups. The total bilirubin, albumin, GGT, and BUN values were similar for both groups. The BMI, AST, ALT, ALP, TG, TC, HOMA-IR, UA, and creatinine values of the NAFLD group were found to be significantly higher than those of controls. A positive correlation was found between the NAFLD stage and UA and creatinine values. On the other hand, BUN values did not show any correlation with the NAFLD stage (Table 2). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.